Spermidine has attracted scientific interest in everything from cell recycling to cognitive aging, but the evidence needed for routine human use has not yet emerged.
Research: Gerontological insights into the natural metabolite spermidine in aging and age-related diseases. Image credit: Corona Borealis Studio / Shutterstock
In a recent “Article in Press” review published in the journal npj agingResearchers considered mechanistic, preclinical, and clinical evidence to evaluate spermidine’s anti-aging properties. Spermidine is a ubiquitous natural polyamine and a calorie restriction mimic that is essential for cell proliferation and tissue homeostasis.
The review results highlighted that while spermidine may partially restore autophagic flux through the eIF5A-TFEB axis and improve mitochondrial function in experimental models and extend healthspan in animal models, clinical outcomes in humans remain complex and context-dependent.
Specifically, high-dose oral supplements of up to 40 mg per day have demonstrated a favorable short-term human safety profile, but translational efficacy against cardiovascular disease and neurological conditions has not yet been established. Taken together, these findings position spermidine as a promising candidate for future research in personalized aging research.
background
The United Nations’ 2022 World Population Prospects predicts that the world’s population aged 65 and over will reach 1.6 billion by 2050, highlighting the urgent need for medical intervention to prevent organ decline.
Spermidine and spermine are polyamines, while putrescine is a related diamine and metabolic precursor. It has been previously scientifically established that these compounds play important roles in controlling cell differentiation, proliferation, and autophagic clearance.
In apparently healthy individuals, endogenous spermidine concentrations gradually decline with age across human blood fractions, including peripheral blood mononuclear cells (PBMCs) and red blood cells (RBCs). Mechanistically, spermidine functions as a calorie restriction mimic and as a downstream effector of nutrient sensing networks such as fasting and rapamycin. This molecule inhibits the acetyltransferase EP300 by competing with aspirin’s active metabolite, salicylic acid, for acetyl coenzyme A binding, a common proximal molecular target.
Unfortunately, although preclinical models have shown robust lifespan extension across yeast, worms, flies, and rodents, it remains unclear whether these beneficial effects translate into clinical benefit in humans, and effects may vary by disease.
About research
This narrative review outlines the therapeutic potential and safety margins of spermidine in aging and age-related pathologies based on evidence from multi-omics datasets, mechanical rodent models, and clinical trial cohorts.
This review discusses the results of studies using single-cell transcriptomics, stable isotope-resolved metabolomics (SIRM), high-performance liquid chromatography-mass spectrometry (HPLC-MS), mitochondrial bioenergetics, and epigenetic histone deacetylation.
The central molecular mechanism discussed in this review is the deoxyhypusine synthase-dependent (DHPS) chemical modification known as hypusination of eukaryotic translation initiation factor 5A (eIF5A). This pathway has previously been described to post-translationally promote translation of transcription factor EB (TFEB) and autophagy-related gene 7 (ATG7) to support autophagic flux.
Human intervention evaluations reviewed trial regimens ranging from 1.5 to 3.3 mg daily of spermidine from rice germ extract and 40 mg of high-purity spermidine trihydrochloride (hpSPD) daily in healthy elderly cohorts, patients with subjective cognitive decline (SCD), and cardiovascular disease trials, including the ongoing 24 mg/day POLYCAD trial.
Research results
Synthesized preclinical data revealed that administration of spermidine in drinking water for 6 months significantly attenuated age-related phenotypes and reduced telomere attrition in mice. Another experimental study also found that spermidine may improve mitochondrial function and adenosine triphosphate (ATP) production in cells and animal models.
Metabolomic profiling identified commensal gut bacteria, particularly Bacteroides species, as important contributors to luminal polyamine biosynthesis via the arginine-agmatine pathway.
In a short-term safety study, hpSPD trihydrochloride 40 mg/day administered for 28 days was well tolerated and safe with no side effects in elderly men. Furthermore, we found that daily supplementation with 3.3 mg of spermidine from rice germ extract improved biomarkers of autophagy and cardiometabolic health.
Prospective population-based studies have similarly demonstrated an association between increased dietary spermidine intake and reduced cardiovascular disease and cancer-related mortality. However, intervention trials have yielded mixed results. In SmartAge, a 12-month phase IIb trial in older adults with SCD, spermidine did not improve memory or biomarkers compared to placebo.
Exploratory analyzes suggest possible effects on verbal memory and tissue inflammation, but these results require confirmation, including studies using higher doses. Importantly, this review identified context-specific concerns. Elevated plasma polyamines are associated with an increased risk of post-stroke cognitive impairment (PSCI) in ischemic stroke patients, and spermidine in the glioblastoma tumor microenvironment has been reported to promote tumor progression by inhibiting CD8+ T cell function.
conclusion
This review suggests that spermidine is a versatile, multi-targeted geroprotector candidate that counters core hallmarks of aging, in part by restoring autophagic capacity via the eIF5A-TFEB axis.
However, the authors emphasize that clinical application requires caution, as efficacy in humans may also be influenced by baseline polyamine levels, metabolic conversion to spermine, and the individual gut and disease microenvironment. Future clinical trials should prioritize large, long-term cohorts to establish optimal dosing regimens and identify specific disease settings before considering routine prophylactic use of spermidine in longevity medicine.
Reference magazines:
- Jiang, Z., Tong, S., Kirkland, J.L., and Sun, Y. (2026). Gerontological insights into the natural metabolite spermidine in aging and age-related diseases. Press article. npj aging. Doi: 10.1038/s41514-026-00448-9. https://www.nature.com/articles/s41514-026-00448-9
